Group B Streptococcus Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.
Condition: Infection by Streptococcus Group BIntervention: Biological: GBS-NN vaccineSponsor: Minervax ApSRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2015 Category: Research Source Type: clinical trials
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
Condition: Group B Streptococcus InfectionsInterventions: Biological: GBS Vaccine; Biological: GBS VaccineSponsors: Novartis Vaccines; NovartisNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2014 Category: Research Source Type: clinical trials
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
Condition: Group B Streptococcus InfectionsInterventions: Biological: GBS Vaccine; Biological: GBS VaccineSponsor: Novartis VaccinesRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2014 Category: Research Source Type: clinical trials
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
Condition: Group B Streptococcus InfectionsInterventions: Biological: GBS Vaccine; Biological: GBS VaccineSponsor: Novartis VaccinesRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2014 Category: Research Source Type: clinical trials
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
Condition: Group B Streptococcus InfectionsInterventions: Biological: GBS Vaccine; Biological: GBS VaccineSponsor: Novartis VaccinesNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2014 Category: Research Source Type: clinical trials
Quasi Experiment of Prenatal Probiotics Against Group B Streptococcus Colonization
Condition: PregnancyIntervention: Dietary Supplement: Probiotic dietary supplementSponsors: Marquette University; Aurora Health Care; University of Wisconsin, MadisonCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2014 Category: Research Source Type: clinical trials
